91 related articles for article (PubMed ID: 28637988)
21. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.
Devoogdt N; Hassanzadeh Ghassabeh G; Zhang J; Brys L; De Baetselier P; Revets H
Proc Natl Acad Sci U S A; 2003 May; 100(10):5778-82. PubMed ID: 12732717
[TBL] [Abstract][Full Text] [Related]
22. [Application of genome-wide microarray for screening genes related to peritoneal metastasis of colorectal cancer].
Liu F; Guo JB; Shen ZY; Mu TY; Zhi PK; Li GX
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):400-3. PubMed ID: 22445993
[TBL] [Abstract][Full Text] [Related]
23. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
[TBL] [Abstract][Full Text] [Related]
24. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
[TBL] [Abstract][Full Text] [Related]
25. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
[TBL] [Abstract][Full Text] [Related]
26. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
27. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection.
Choi BD; Jeong SJ; Wang G; Kim HJ; Kim BO; Hwang HK; Lim DS; Kim SH; Jeong MJ
J Endod; 2009 Jul; 35(7):997-1002. PubMed ID: 19567322
[TBL] [Abstract][Full Text] [Related]
28. Secretory leukocyte peptidase inhibitor and lung cancer.
Nukiwa T; Suzuki T; Fukuhara T; Kikuchi T
Cancer Sci; 2008 May; 99(5):849-55. PubMed ID: 18380788
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
30. The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils.
Jacobsen LC; Sørensen OE; Cowland JB; Borregaard N; Theilgaard-Mönch K
J Leukoc Biol; 2008 May; 83(5):1155-64. PubMed ID: 18285402
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor effect of SLPI on mammary but not colon tumor growth.
Amiano NO; Costa MJ; Reiteri RM; Payés C; Guerrieri D; Tateosian NL; Sánchez ML; Maffia PC; Diament M; Karas R; Orqueda A; Rizzo M; Alaniz L; Mazzolini G; Klein S; Sallenave JM; Chuluyan HE
J Cell Physiol; 2013 Feb; 228(2):469-75. PubMed ID: 22767220
[TBL] [Abstract][Full Text] [Related]
32. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
33. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
Zhang X; Liu SS; Ma J; Qu W
Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
[TBL] [Abstract][Full Text] [Related]
34. Clobetasol down-regulates SLPI expression in U937 monocytoid cells.
Okumura N; Yoshida H; Kitagishi Y; Nishimura Y; Matsuda S
Int J Mol Med; 2012 Feb; 29(2):324-6. PubMed ID: 22076618
[TBL] [Abstract][Full Text] [Related]
35. Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma.
Chen J; Yang B; Zhang S; Ling Y; Ye J; Jia Z; Cao J
Cancer Gene Ther; 2012 May; 19(5):328-35. PubMed ID: 22388454
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
Jana NK; Gray LR; Shugars DC
J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
[TBL] [Abstract][Full Text] [Related]
37. Estrogen induces expression of secretory leukocyte protease inhibitor in rat uterus.
Chen D; Xu X; Cheon YP; Bagchi MK; Bagchi IC
Biol Reprod; 2004 Aug; 71(2):508-14. PubMed ID: 15044260
[TBL] [Abstract][Full Text] [Related]
38. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
[TBL] [Abstract][Full Text] [Related]
39. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa.
Wex T; Mönkemüller K; Kuester D; Weise S; Kropf S; Fry LC; Stahr A; Völkel S; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):150-8. PubMed ID: 19212204
[TBL] [Abstract][Full Text] [Related]
40. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
